Literature DB >> 4985160

Cross-reactivity studies of horse, goat and rabbit anti-lymphocyte globulin.

H Ameniya, N Kashiwagi, C W Putnam, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4985160      PMCID： PMC1712782     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  10 in total

1.  A STUDY OF THE ALPHA-2-MARCROGLOBULIN HOMOLOGUES OF VARIOUS SPECIES.

Authors:  K JAMES
Journal:  Immunology       Date:  1965-01       Impact factor: 7.397

2.  Serum sickness: serologic studies following prophylactic tetanus antitoxin.

Authors:  C E ARBESMAN; S Z KANTOR; N R ROSE; E WITEBSKY
Journal:  J Allergy       Date:  1960 May-Jun

3.  Diffusion-in-gel methods for immunological analysis.

Authors:  O OUCHTERLONY
Journal:  Prog Allergy       Date:  1958

4.  [A micro-method of immuno-electrophoresis].

Authors:  J J SCHEIDEGGER
Journal:  Int Arch Allergy Appl Immunol       Date:  1955

5.  Chromic chloride: a coupling reagent for passive hemagglutination reactions.

Authors:  E R Gold; H H Fudenberg
Journal:  J Immunol       Date:  1967-11       Impact factor: 5.422

6.  Clinical reactions and serologic changes after the administration of heterologous antilymphocyte globulin to human recipients of renal homografts.

Authors:  N Kashiwagi; C O Brantigan; L Brettschneider; C G Groth; T E Starzl
Journal:  Ann Intern Med       Date:  1968-02       Impact factor: 25.391

7.  Immunosuppressive activity of allogeneic anti-lymphocyte serum in the rat.

Authors:  K Ono; C W DeWitt; J H Wallace; E S Lindsey
Journal:  Transplantation       Date:  1969-02       Impact factor: 4.939

8.  Notes on the preparation and assay of anti-lymphocytic serum for use in mice.

Authors:  S V Jooste; E M Lance; R H Levey; P B Medawar; M Ruszkiewicz; R Sharman; R N Taub
Journal:  Immunology       Date:  1968-11       Impact factor: 7.397

9.  A trial with heterologous antilymphocyte globulin in man.

Authors:  T E Starzl; L Brettschneider; I Penn; R W Schmidt; P Bell; N Kashiwagi; C M Townsend; C W Putnam
Journal:  Transplant Proc       Date:  1969-03       Impact factor: 1.066

10.  The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions.

Authors:  Y Iwasaki; K A Porter; J R Amend; T L Marchioro; V Zühlke; T E Starzl
Journal:  Surg Gynecol Obstet       Date:  1967-01
  10 in total
  5 in total

1.  The nature of antiplatelet activity in antilymphoblast ALG--with special reference to cross-reacting antibody, immunochemical characterization, and Coombs' positive thrombocytopenia in ALG-treated renal recipients.

Authors:  H Amemiya; T Yokoyama; C W Putnam; M Torisu; T E Starzl
Journal:  Clin Exp Immunol       Date:  1972-03       Impact factor: 4.330

2.  The antigenic and immunosuppressive properties of normal and antilymphocytic equine IgG subfractions.

Authors:  R A Allardyce; N F Anderson; J P Vaerman; K James
Journal:  Clin Exp Immunol       Date:  1973-02       Impact factor: 4.330

3.  The mechanism behind the effect of ALG on platelets in vivo.

Authors:  A Henricsson; B Husberg; S E Bergentz
Journal:  Clin Exp Immunol       Date:  1977-09       Impact factor: 4.330

4.  The reduction of antigenicity of heterologous antilymphocyte serum with acid Taka-protease.

Authors:  H Amemiya; T Yokoyama; M Torisu; C W Putnam; J T Anderson; T E Starzl
Journal:  Clin Exp Immunol       Date:  1972-05       Impact factor: 4.330

5.  The intravenous administration of equine antilymphocytic globulin in renal transplant recipients and the detection of circulating antibodies to equine globulin.

Authors:  K James; D M Pullar; J B Morton; R G Dalton; B Nolan; M F Woodruff
Journal:  Clin Exp Immunol       Date:  1971-04       Impact factor: 4.330
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.